Oncological Center Dusseldorf

The clinic is accredited by international organizations JCI (Joint Commission International) and ISO.

Each year, the clinic performs over 5,000 oncological surgeries and conducts more than 10,000 chemotherapy courses.

The clinic’s multidisciplinary medical team includes over 30 oncologists and hematologists, who have undergone training at the world’s leading medical centers.

St. Mary’s Clinic in Düsseldorf provides cutting-edge diagnostic and treatment methods for oncological diseases. The center includes a specialized oncohematology department, dedicated to the treatment of lymphomas, lymphocytic leukemia, and other blood disorders. The clinic offers not only modern therapeutic approaches but also comprehensive palliative care for patients with advanced-stage cancer.

The hematology department has 50 inpatient beds, where patients receive treatment for leukemia (both acute and chronic), as well as various types of malignant lymphatic system disorders, including Hodgkin’s lymphoma. In its early stages, Hodgkin’s lymphoma may only manifest as enlarged lymph nodes, but as it progresses, it can affect internal organs such as the liver, spleen, and bone marrow. To ensure an accurate diagnosis, the clinic’s specialists perform lymph node biopsies, laboratory tests, CT scans, PET-CT, MRI, and bone marrow biopsies. Upon confirmation of the diagnosis, an individualized treatment plan is developed, which may include radiation therapy, chemotherapy, and surgical intervention. Treatment programs are tailored for both adults and children, considering the specifics of the disease in different age groups.

Non-Hodgkin’s lymphomas also respond well to therapy, although complete recovery depends on the specific type of disease, tumor histology, and clinical progression. Highly precise molecular and biological studies allow oncologists to determine the malignancy grade, recurrence risk, and optimal therapeutic protocol.

Special attention is given to leukemia treatment. The acute form of leukemia is most commonly diagnosed in children and can remain asymptomatic for a long time. To detect the disease, specialists conduct bone marrow aspiration and biopsy, as well as molecular genetic tests to identify specific mutations in leukemic cells. Additional examinations, such as abdominal ultrasound and CT scans, help determine the presence of metastases and the disease stage.

The clinic operates an early cancer detection program, significantly improving the chances of successful treatment. Through the integration of innovative diagnostic methods and a multidisciplinary approach, patients receive high-quality medical care that meets international standards.